Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV002642394 | SCV002969108 | likely pathogenic | Maple syrup urine disease | 2023-06-12 | criteria provided, single submitter | clinical testing | This sequence change affects a donor splice site in intron 7 of the BCKDHA gene. It is expected to disrupt RNA splicing. Variants that disrupt the donor or acceptor splice site typically lead to a loss of protein function (PMID: 16199547), and loss-of-function variants in BCKDHA are known to be pathogenic (PMID: 16786533, 22593002). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. ClinVar contains an entry for this variant (Variation ID: 1929553). Disruption of this splice site has been observed in individual(s) with maple syrup urine disease (PMID: 31980395). This variant is not present in population databases (gnomAD no frequency). |
Baylor Genetics | RCV004571195 | SCV005058092 | pathogenic | Maple syrup urine disease type 1A | 2023-11-28 | criteria provided, single submitter | clinical testing |